Key result
Anatomically guided cardioneuroablation achieves ~85% acute success, with sustained syncope freedom at follow-up.
Why the study?
Omnipolar Technology Near Field (OTNF) is a novel automated spectral mapping algorithm, and its systematic comparison with fragmentation mapping during cardioneuroablation (CNA) for refractory vasovagal syncope had not previously been reported.
Does a streamlined anatomically guided cardioneuroablation approach achieve acute vagal denervation and syncope freedom, and how does Omnipolar Technology Near Field (OTNF) mapping compare with fragmentation mapping in detecting ganglionated plexi in patients with refractory vasovagal syncope?
Observational (n=26)
Yes
Does a streamlined anatomically guided cardioneuroablation approach achieve acute vagal denervation and syncope freedom, and how does Omnipolar Technology Near Field (OTNF) mapping compare with fragmentation mapping in detecting ganglionated plexi in patients with refractory vasovagal syncope?
A simplified, imaging-free anatomical cardioneuroablation approach is safe and effective for refractory vasovagal syncope, while OTNF and fragmentation mapping demonstrate modest concordance and capture partially non-overlapping electrophysiological information at ganglionated plexi sites.
Background Cardioneuroablation (CNA) is an established catheter‐based therapy for refractory vasovagal syncope (VVS), targeting atrial ganglionated plexi (GPs) by radiofrequency ablation. Omnipolar Technology Near Field (OTNF) is a novel automated spectral mapping algorithm integrated within the EnSite X system; its systematic comparison with fragmentation mapping during CNA has not previously been reported. Objectives To evaluate the feasibility, safety, and efficacy of a streamlined, imaging‐free anatomically guided CNA approach and to compare real‐time OTNF mapping at three spectral thresholds with fractionation analysis in detecting GPs at anatomically consistent locations. Methods Twenty‐six consecutive patients (mean age 43.9 ± 16.4 years; 69% female; ≥ 3 VVS episodes/year) were enrolled prospectively at two French centres. All procedures used an HD Grid catheter for bilateral OTNF and fractionation mapping, followed by sequential ablation of five GP sites. Acute success was defined as heart rate increase > 50% from baseline and blunted atropine response (< 25% increment). Directional discordance between fractionation and OTNF map was assessed by McNemar's exact test. Results Acute procedural success was achieved in 22 out of 26 patients (84.6%), with no complications. Mean procedure time was 95.2 ± 20.5 min. CNA produced significant vagal denervation: heart rate increased from 60.2 ± 12.9 to 88.1 ± 18.2 bpm ( p < 0.003), AH interval shortened from 97.6 ± 22.9 to 78.2 ± 21.7 ms ( p = 0.007), Wenckebach cycle length decreased from 441.5 ± 118.9 to 330.0 ms ( p < 0.003) and SNRT decreased from 1235.0 ± 273.7 to 1028.4 ± 235.1 ms ( p = 0.003). At 400 Hz, OTNF showed significantly higher signal positivity than fractionation mapping at the LSGP (concordance 57.7%) and RIGP (concordance 65.4%). At 500 and 600 Hz, no directional asymmetry was detected while concordance remained below 70% at these sites. At a median follow‐up of 20.2 ± 7.6 months, 81% of patients were free from syncope. Conclusions A simplified, anatomical CNA approach is safe, feasible, and effective. OTNF and fragmentation signals mapping shows modest concordance at five anatomically consistent GP locations, confirming that those strategies capture partially non‐overlapping electrophysiological information.
No takes yet. Share an insight, caveat, or question.
Jabbour et al. (2026) conducted an observational in Refractory vasovagal syncope (VVS) (n=26). Anatomically guided cardioneuroablation with Omnipolar Technology Near Field (OTNF) mapping vs. Fractionation mapping was evaluated on Acute procedural success (heart rate increase >50% from baseline and blunted atropine response <25% increment) and freedom from syncope at follow-up. Anatomically guided cardioneuroablation achieved 84.6% acute success and 81% syncope freedom at 20.2 months, with <70% concordance between OTNF and fragmentation mapping.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: